MERCK CHARGING US 40 TIMES WHAT IT COSTS TO MAKE GOVT-FINANCED COVID PILL

Oct 7, 2021

Merck’s new ‘not Ivermectin’ Covid-19 treatment, molnupiravir, costs $17.74 to produce – yet the company is charging the US government $712 for the treatment – a 40x markup,